Home
About
Overview
Sharing Data
ORCID
Help
History (1)
ß1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
ß1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations.
ß1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations. FASEB J. 2022 12; 36(12):e22629.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Hemangioma, Cavernous, Central Nervous System
Human Umbilical Vein Endothelial Cells
Humans
Integrin beta1
Integrins
Mice
Microtubule-Associated Proteins
authors with profiles
Issam Awad
Robert Shenkar